1型和2型糖尿病成人自主神经系统失调症状与糖尿病痛苦的关系
研究纳入556例1型糖尿病(研究1)和299例2型糖尿病(研究2)成人,通过互联网调查评估自主神经系统反应性症状与糖尿病痛苦的关系。控制协变量后,糖尿病痛苦严重程度显著预测所有分量表上自主神经系统症状T分升高(P≤0.05),高糖尿病痛苦者BPQ评分最高。
要点
- 糖尿病痛苦严重程度显著预测自主神经系统症状T分升高(P≤0.05)。
- 高糖尿病痛苦组在BPQ所有分量表上得分最高。
- 研究显示1型和2型糖尿病中自主神经系统反应性与糖尿病痛苦相关。
核心结论
- 研究显示1型和2型糖尿病样本中自主神经系统反应性与糖尿病痛苦存在关系。
研究设计与样本
- 研究1纳入556例1型糖尿病成人,研究2纳入299例2型糖尿病成人,均完成互联网调查。
- 使用躯体感知问卷(BPQ)评估自主神经系统反应性症状,DDS-T1和DDS-17评估糖尿病痛苦,GAD-7评估焦虑,PHQ-8评估抑郁。
主要发现
- 研究1:平均年龄45.1(SD 15.7)岁,女性73.2%,白人95.3%,自报HbA1c均值6.7%(SD 1.0%),T1D诊断平均病程20.6(SD 14.7)年,72.5%使用胰岛素泵,DDS-T1均值2.3(SD 0.8;中度严重),BPQ膈上反应性分量表T分均值48.9(SD 8.4),膈下反应性分量表T分均值50.6(SD 8.9)。
- 研究2:平均年龄60.2(SD 13.6)岁,女性58.7%,白人82.9%,自报HbA1c均值7.0%(SD 1.2%),51.8%使用口服降糖药,39.9%使用口服和注射药物,T2D诊断平均病程15.0(SD 10.0)年,DDS-17均值2.3(SD 1.0;中度严重),BPQ膈上反应性分量表T分均值49.9(SD 9.4),膈下反应性分量表T分均值52.0(SD 8.8)。
- 控制协变量后,DDS-T1/DDS-17严重程度显著预测所有分量表上自主神经系统症状T分升高(所有P≤0.05),高DDS组BPQ评分最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the association of autonomic nervous system (ANS) dysregulation symptoms and diabetes distress (DD) in adults with type 1 diabetes (T1D; study 1) and type 2 diabetes (T2D; study 2). RESEARCH DESIGN AND METHODS: A total of 556 adults with T1D and 299 with T2D completed the Body Perception Questionnaire (BPQ) to assess ANS reactivity symptoms, diabetes distress (via Diabetes Distress Scale T1 [DDS-T1], and DDS-17), anxiety (via General Anxiety Disorder 7 [GAD-7]) scale, depression (via Patient Health Questionnaire-8 [PHQ-8]), and demographic variables via internet surveys. RESULTS: In study 1, participants' mean age was 45.1 (SD 15.7) years and most were female (73.2%) and White (95.3%). The mean self-reported HbA1c was 6.7% (SD 1.0%); mean duration of T1D diagnosis 20.6 (SD 14.7) years; and 72.5% of participants reported using an insulin pump. The mean DDS-T1 score was 2.3 (SD 0.8; moderate severity). The BPQ mean T score was 48.9 (SD 8.4) for supradiaphragmatic and 50.6 (SD 8.9) for subdiaphragmatic reactivity subscales. In study 2, participants' mean age was 60.2 (SD 13.6) years, 58.7% were female, and 82.9% were White. The mean self-reported HbA1c was 7.0% (SD 1.2%), and 51.8% of participants were treated with oral hypoglycemic agents and 39.9% used oral and injectable medications. The mean duration of T2D diagnosis was 15.0 (SD 10.0) years. The mean DDS-17 score was 2.3 (SD 1.0; moderate severity) and BPQ mean T score was 49.9 (SD 9.4) for supradiaphragmatic and 52.0 (SD 8.8) for subdiaphragmatic reactivity subscales. Controlling for covariates, severity of DDS-T1/DDS-17 significantly predicted elevations in ANS symptom T scores on all subscales (P ≤ 0.05 for all), with "high" DDS having the highest BPQ scores. CONCLUSIONS: These findings demonstrate a relationship between ANS reactivity and DDS in T1D and T2D samples.
引用
- de Groot M, Myers BA, Stump TE, et al. Symptoms of Autonomic Nervous System Dysregulation and Diabetes Distress in Adults With Type 1 and Type 2 Diabetes. Diabetes Care. 2025. PMID: 40163388. doi:10.2337/dc24-2614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。